TrumpRx may not offer the lowest drug prices for many consumers

TrumpRx.gov lists discounted brand-name medicines for cash-paying customers, but an analysis found nearly half of the 43 brand drugs on the site have generic equivalents that can be cheaper elsewhere.

President Donald Trump launched the TrumpRx.gov website in early February to list discounted brand-name medicines for cash-paying customers. The site shows prices and directs users to manufacturers or coupons but does not process insurance claims or accept orders. White House officials say the site focuses on lower prices for branded drugs after negotiating deals with some companies. Analysts and consumer advocates say savings are mixed because many listed brand drugs have cheaper generic alternatives available through other retailers. Key points: - The site currently lists 43 brand-name drugs from five companies; a Public Citizen analysis found 20 of those have generic equivalents available elsewhere. - TrumpRx lists cash prices and referral instructions but does not handle insurance claims or direct ordering. - Some brand prices are substantially discounted from list price, yet independent sites such as GoodRx and Cost Plus Drugs often show lower prices for generics (for example, a listed brand drug priced at about $200 compared with generic coupon prices near $12). - Entrepreneur Mark Cuban’s Cost Plus Drugs said it offers lower prices for about 90% of the drugs on TrumpRx because it carries generic versions, though TrumpRx shows much lower prices for some fertility drugs like cetrotide. - The site includes popular weight-loss drugs at the manufacturers’ cash prices; the administration also announced deals for Medicare coverage of Wegovy and Zepbound with an average government price of $245 per monthly dose and a projected $50 monthly copay, with coverage expected in spring or summer 2026. Summary: TrumpRx creates a government-listed channel for cash prices on branded medicines but does not automatically guarantee the lowest option for all consumers. Analysts note the site’s focus on brand-name products means cheaper generics may still be available through other sellers. The White House plans to add products from additional companies, and Medicare coverage changes for certain weight-loss drugs are scheduled to roll out in 2026.